Floatz logo

Cyclophosphamide

Sarcoma

Essen BiotechSmall moleculePhase 2Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
73/ 100

Competitive context

108 Active assets in the Sarcoma cohort.

Asset / SponsorPhaseRating
Etoposide
National Cancer Institute (NCI)
Phase 2BB
Isocyclophosphamide
City of Hope Medical Center
Phase 3BB
Carboplatin
OHSU Knight Cancer Institute
Phase 2BB
Cis-Diamminedichloroplatinum Ii
Roswell Park Cancer Institute
Phase 2BB
Adriamycin
City of Hope Medical Center
Phase 3BB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
mycosis fungoidesActive
BBB
Indicative · Phase 4
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →